NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

323

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma

Interventions

GENETIC

BRCA testing

BRCA 1 and 2 testing

Trial Locations (1)

Istituto Europeo di Oncologia, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER

NCT06972693 - NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma | Biotech Hunter | Biotech Hunter